# Neurotechnology Investors

> Neurotechnology Investors is a VC fund backing Medical and Medical Device. See 7 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Location: Palo Alto, United States
- Total investments: 7
- Last investment: Jul 2024
- Lead investor: 43%
- Last updated: Aug 2026
- Website: https://themdadvantage.com/

Neurotechnology Investors is a VC fund in Palo Alto focused on Medical and Medical Device. Neurotechnology Investors offers an investment vehicle for physicians who are in a position to evaluate the probable success of technologies and allows them to invest together as a group without the standard trappings of typical investment funds.

## Contacts

5 contacts available for Neurotechnology Investors. Shizune tracks 1 team members at Neurotechnology Investors. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/neurotechnology-investors-nti?utm_source=investor_profile

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Medical | 2 | 29% |
| Medical Device | 2 | 29% |
| Health Care | 1 | 14% |
| Neuroscience | 1 | 14% |
| Biotechnology | 1 | 14% |

7 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Seed | 1 | 14% |
| Series A | 1 | 14% |
| Series B | 1 | 14% |
| Series C | 1 | 14% |
| Series D | 1 | 14% |

6 stages tracked in total.

### Country

| Country | Investments | Share |
| --- | --- | --- |
| United States | 2 | 29% |
| Spain | 1 | 14% |

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| Martin Dieck | Managing Member | 0 | — |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Radical Catheter Technologies | Radical Catheter Technologies is a medical device firm developing the next generation of endovascular access and delivery technologies. | $20M | Venture - Series Unknown | Jul 22, 2024 |  |
| FreeOx Biotech | Based on the knowledge of oxidative stress and uric acid, Freeox Biotech is developing neuroprotective therapies to reduce the damage resulting from ischemia and in this way improve the recovery of the patients. Ox-01 is Uric Acid used as a medicinal product. Ox-01 has a proven effect in preventing the damage caused by reperfusion after stroke.Ox-02 Uricoline is a molecule resulting from the association of Ox-01 and Citicoline. Citicoline is an intermediate in the generation of phosphatidylcholine from choline. | $1.5M | Seed | Jun 28, 2024 |  |
| Synchron | Synchron manufactures and markets a medical device that can be delivered to the brain with a catheter to record neuron signals that might be used to control an advanced prosthetic. | $75M | Series C | Dec 16, 2022 |  |
| Synchron | Synchron manufactures and markets a medical device that can be delivered to the brain with a catheter to record neuron signals that might be used to control an advanced prosthetic. | $75M | Series C | Dec 15, 2022 |  |
| Synchron | Synchron manufactures and markets a medical device that can be delivered to the brain with a catheter to record neuron signals that might be used to control an advanced prosthetic. | $40M | Series B | Jun 03, 2021 |  |
| Synchron | Synchron manufactures and markets a medical device that can be delivered to the brain with a catheter to record neuron signals that might be used to control an advanced prosthetic. | $10M | Series A | Apr 04, 2017 |  |
| Synchron | Synchron manufactures and markets a medical device that can be delivered to the brain with a catheter to record neuron signals that might be used to control an advanced prosthetic. | $200M | Series D |  |  |

7 of 7 investments shown.

## Co-investors
- [Khosla Ventures](https://shizune.co/investors/profile/khosla-ventures) — VC Fund, 4 deals together
- [METIS innovative](https://shizune.co/investors/profile/metis-innovative) — VC Fund, 4 deals together
- [Forepont Capital Partners](https://shizune.co/investors/profile/forepont-capital-partners) — VC Fund, 3 deals together
- [ID8 Investments](https://shizune.co/investors/profile/id8-investments) — VC Fund, 3 deals together
- [University of Melbourne](https://shizune.co/investors/profile/the-university-of-melbourne) — VC Fund, 3 deals together
- [ARCH Venture Partners](https://shizune.co/investors/profile/arch-venture-partners) — VC Fund, 2 deals together

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund

## FAQ

### What does Neurotechnology Investors invest in?

Neurotechnology Investors invests primarily in Medical, Medical Device and Health Care startups, most often at Seed and Series A stage. Most of the 7 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### How do I contact Neurotechnology Investors?

Public channels for Neurotechnology Investors include the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at Neurotechnology Investors?

The team at Neurotechnology Investors includes Martin Dieck (Managing Member). The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co